N01.5 Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis

Name of the Condition

• Rapidly Progressive Nephritic Syndrome with Diffuse Mesangiocapillary Glomerulonephritis
• ICD-10 Code: N01.5

Summary

Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis is a severe kidney disorder marked by rapid loss of kidney function due to inflammation and structural changes in the glomeruli, the kidney's filtering units. The term "diffuse mesangiocapillary glomerulonephritis" refers to widespread thickening of the glomerular capillary walls and mesangium, a key pathological feature. This condition typically presents with hematuria (blood in urine), proteinuria (excess protein in urine), and a swift decline in renal function, often progressing to acute kidney injury within weeks. Urgent diagnosis and treatment are essential to prevent irreversible damage.

Causes

The condition is primarily driven by immune-mediated damage to the glomeruli, though the exact trigger may vary. It is often associated with underlying autoimmune processes, such as systemic lupus erythematosus or vasculitis, or may follow infections (e.g., hepatitis C). In some cases, the cause remains idiopathic (unknown), but the aggressive clinical course suggests a severe immune response targeting kidney tissue.

Risk Factors

• Autoimmune conditions: Diseases like lupus, vasculitis, or anti-glomerular basement membrane disease.
• Infections: Chronic or recent infections, particularly viral (e.g., hepatitis) or bacterial.
• Genetic predisposition: Family history of kidney disease or autoimmune disorders.
• Age: More common in adults, though it can occur at any age.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (excess protein in urine, sometimes causing foamy urine).
• Hypertension (high blood pressure).
• Rapid decline in kidney function (e.g., rising serum creatinine levels).
• Edema (swelling, especially in the legs or face).
• Fatigue or malaise.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and renal biopsy. Urinalysis typically shows hematuria and proteinuria, while blood tests may reveal elevated creatinine or urea levels indicating impaired kidney function. A renal biopsy is critical to confirm the presence of diffuse mesangiocapillary glomerulonephritis and rule out other causes. Imaging studies (e.g., ultrasound) may assess kidney size and structure.

Treatment Options

Treatment focuses on suppressing the immune response to halt kidney damage. Corticosteroids (e.g., prednisone) and immunosuppressants (e.g., cyclophosphamide) are commonly used. Plasmapheresis may be employed in severe cases to remove harmful antibodies. Managing blood pressure and proteinuria with ACE inhibitors or ARBs is also standard. In advanced cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis depends on the speed of diagnosis and response to treatment. Early intervention improves outcomes, but some patients may progress to end-stage renal disease. Regular follow-up with nephrology is essential to monitor kidney function, adjust medications, and manage complications. Long-term care may include ongoing immunosuppression and lifestyle modifications.

Complications

• End-stage renal disease (ESRD) requiring dialysis or transplantation.
• Hypertension (persistent or worsening).
• Electrolyte imbalances (e.g., hyperkalemia).
• Increased risk of infections due to immunosuppression.
• Cardiovascular disease (e.g., heart failure) from chronic kidney disease.

Lifestyle & Prevention

• Maintain a low-sodium, kidney-friendly diet to manage blood pressure.
• Avoid nephrotoxic medications (e.g., certain NSAIDs) unless prescribed.
• Stay hydrated and monitor urine output for changes.
• Control underlying conditions (e.g., diabetes, hypertension) to reduce kidney stress.
• Avoid smoking, which can worsen kidney function.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden swelling (edema) in the legs, ankles, or face.
• Blood in urine (red or brown urine).
• Severe fatigue or confusion.
• Rapid weight gain from fluid retention.
• Decreased urine output.

Tips for Medical Coders

Document the presence of diffuse mesangiocapillary glomerulonephritis (confirmed via biopsy) to support the N01.5 code. Include details on clinical manifestations (e.g., hematuria, proteinuria) and any associated conditions (e.g., autoimmune disease) to ensure accurate coding. Verify that the code aligns with the specific pathological findings and clinical course described in the medical record.